These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37474006)

  • 1. Ambivalence and contingencies: A qualitative examination of peer recovery coaches' attitudes toward medications for opioid use disorder.
    Pasman E; O'Shay S; Brown S; Madden EF; Agius E; Resko SM
    J Subst Use Addict Treat; 2023 Dec; 155():209121. PubMed ID: 37474006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ambivalence and Stigma Beliefs About Medication Treatment Among Young Adults With Opioid Use Disorder: A Qualitative Exploration of Young Adults' Perspectives.
    Bagley SM; Schoenberger SF; dellaBitta V; Lunze K; Barron K; Hadland SE; Park TW
    J Adolesc Health; 2023 Jan; 72(1):105-110. PubMed ID: 36216678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "In their mind, they always felt less than": The role of peers in shifting stigma as a barrier to opioid use disorder treatment retention.
    Anvari MS; Kleinman MB; Massey EC; Bradley VD; Felton JW; Belcher AM; Magidson JF
    J Subst Abuse Treat; 2022 Jul; 138():108721. PubMed ID: 35067397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes toward opioid use disorder pharmacotherapy among recovery community center attendees.
    Hoffman LA; Vilsaint CL; Kelly JF
    J Subst Abuse Treat; 2021 Dec; 131():108464. PubMed ID: 34098288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Support for Safe Consumption Sites Among Peer Recovery Coaches.
    Pasman E; Brown S; Agius E; Resko SM
    J Behav Health Serv Res; 2024 Apr; 51(2):219-231. PubMed ID: 37430133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic, social, and clinic influences on opioid treatment program retention in Dar es Salaam, Tanzania: a qualitative study.
    Knight D; Nkya IH; West NS; Yang C; Kidorf M; Latkin C; Saleem HT
    Addict Sci Clin Pract; 2023 Mar; 18(1):19. PubMed ID: 36973794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes Toward Medication for Opioid Use Disorder Among Pregnant and Postpartum Women and People Seeking Treatment.
    Banks DE; Fentem A; Li X; Paschke M; Filiatreau L; Woolfolk C; Cavazos-Rehg P
    J Addict Med; 2023 May-Jun 01; 17(3):356-359. PubMed ID: 37267191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Stigma on Clinician Training for Opioid Use Disorder Care: A Qualitative Study in a Primary Care Learning Collaborative.
    Klusaritz H; Bilger A; Paterson E; Summers C; Barg FK; Cronholm PF; Saine ME; Sochalski J; Doubeni CA
    Ann Fam Med; 2023 Feb; 21(Suppl 2):S31-S38. PubMed ID: 36849482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stigmatization of medications for opioid use disorder in 12-step support groups and participant responses.
    Andraka-Christou B; Totaram R; Randall-Kosich O
    Subst Abus; 2022; 43(1):415-424. PubMed ID: 34214400
    [No Abstract]   [Full Text] [Related]  

  • 10. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness.
    Swartz N; Adnan T; Peréa F; Baggett TP; Chatterjee A
    J Subst Abuse Treat; 2022 Jul; 138():108752. PubMed ID: 35277306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intervention Stigma toward Medications for Opioid Use Disorder: A Systematic Review.
    Madden EF; Prevedel S; Light T; Sulzer SH
    Subst Use Misuse; 2021; 56(14):2181-2201. PubMed ID: 34538213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences of healthcare and substance use treatment provider-based stigma among patients receiving methadone.
    Carl A; Pasman E; Broman MJ; Lister JJ; Agius E; Resko SM
    Drug Alcohol Depend Rep; 2023 Mar; 6():100138. PubMed ID: 36994374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letting the sun shine on patient voices: Perspectives about medications for opioid use disorder in Florida.
    Sharp A; Carlson M; Howell V; Moore K; Schuman-Olivier Z
    J Subst Abuse Treat; 2021 Apr; 123():108247. PubMed ID: 33612190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary feasibility of integrating tobacco treatment into SUD peer recovery coaching: a mixed-methods study of peer recovery coaches.
    Streck JM; Regan S; Werner M; Glynn A; Villanti AC; Park ER; Wakeman SE; Evins AE; Rigotti NA
    Addict Sci Clin Pract; 2023 Apr; 18(1):25. PubMed ID: 37122035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders.
    Saunders EC; Moore SK; Walsh O; Metcalf SA; Budney AJ; Scherer E; Marsch LA
    J Subst Abuse Treat; 2020 Apr; 111():54-66. PubMed ID: 32076361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes Regarding Medications for Opioid Use Disorder Among Peer Recovery Coaches.
    Suzuki J; Loguidice F; Martin B
    J Addict Med; 2023 Jan-Feb 01; 17(1):101-103. PubMed ID: 35914085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief video intervention to improve attitudes throughout medications for opioid use disorder in a correctional setting.
    Lam JA; Lee HIS; Truong AQ; Macmadu A; Clarke JG; Rich J; Brockmann B
    J Subst Abuse Treat; 2019 Sep; 104():28-33. PubMed ID: 31370982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians.
    Booty MD; Harp K; Batty E; Knudsen HK; Staton M; Oser CB
    J Subst Use Addict Treat; 2023 Jun; 149():209051. PubMed ID: 37084815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "You have to take this medication, but then you get punished for taking it:" lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period.
    Schiff DM; Work EC; Muftu S; Partridge S; MacMillan KDL; Gray JR; Hoeppner BB; Kelly JF; Greenfield SF; Jones HE; Wilens TE; Terplan M; Bernstein J
    J Subst Abuse Treat; 2022 Aug; 139():108765. PubMed ID: 35341614
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.